DRTS
Price
$3.17
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
268.88M
48 days until earnings call
XOMA
Price
$26.96
Change
+$0.85 (+3.26%)
Updated
Jul 3 closing price
Capitalization
322.63M
33 days until earnings call
Interact to see
Advertisement

DRTS vs XOMA

Header iconDRTS vs XOMA Comparison
Open Charts DRTS vs XOMABanner chart's image
Alpha Tau Medical
Price$3.17
Change-$0.00 (-0.00%)
Volume$21.92K
Capitalization268.88M
XOMA Royalty
Price$26.96
Change+$0.85 (+3.26%)
Volume$25.29K
Capitalization322.63M
DRTS vs XOMA Comparison Chart in %
Loading...
DRTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XOMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DRTS vs. XOMA commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRTS is a Buy and XOMA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (DRTS: $3.17 vs. XOMA: $26.96)
Brand notoriety: DRTS and XOMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DRTS: 46% vs. XOMA: 44%
Market capitalization -- DRTS: $268.88M vs. XOMA: $322.63M
DRTS [@Biotechnology] is valued at $268.88M. XOMA’s [@Biotechnology] market capitalization is $322.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRTS’s FA Score shows that 0 FA rating(s) are green whileXOMA’s FA Score has 1 green FA rating(s).

  • DRTS’s FA Score: 0 green, 5 red.
  • XOMA’s FA Score: 1 green, 4 red.
According to our system of comparison, both DRTS and XOMA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRTS’s TA Score shows that 5 TA indicator(s) are bullish while XOMA’s TA Score has 4 bullish TA indicator(s).

  • DRTS’s TA Score: 5 bullish, 3 bearish.
  • XOMA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, DRTS is a better buy in the short-term than XOMA.

Price Growth

DRTS (@Biotechnology) experienced а +5.14% price change this week, while XOMA (@Biotechnology) price change was -1.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

DRTS is expected to report earnings on Aug 21, 2025.

XOMA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XOMA($323M) has a higher market cap than DRTS($269M). XOMA YTD gains are higher at: 2.588 vs. DRTS (2.258). XOMA has higher annual earnings (EBITDA): 6M vs. DRTS (-32.33M). XOMA has more cash in the bank: 92.6M vs. DRTS (51.6M). DRTS has less debt than XOMA: DRTS (12.3M) vs XOMA (114M). XOMA has higher revenues than DRTS: XOMA (13M) vs DRTS (0).
DRTSXOMADRTS / XOMA
Capitalization269M323M83%
EBITDA-32.33M6M-539%
Gain YTD2.2582.58887%
P/E RatioN/AN/A-
Revenue013M-
Total Cash51.6M92.6M56%
Total Debt12.3M114M11%
FUNDAMENTALS RATINGS
XOMA: Fundamental Ratings
XOMA
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
PROFIT vs RISK RATING
1..100
84
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DRTSXOMA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 9 days ago
65%
Bullish Trend 11 days ago
79%
Declines
ODDS (%)
Bearish Trend 15 days ago
73%
Bearish Trend 9 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 3 days ago
50%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
DRTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XOMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATUUF14.670.03
+0.20%
TENAZ ENERGY CORP.
CFNCF146.65N/A
N/A
Cie Financiere Tradition Lausanne ACT
CRBJY32.80N/A
N/A
China Resources Land Ltd.
HUQVF6.53N/A
N/A
Husqvarna AB
VTXXF0.15N/A
N/A
Vertex Minerals Ltd.

DRTS and

Correlation & Price change

A.I.dvisor tells us that DRTS and ARDX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DRTS and ARDX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRTS
1D Price
Change %
DRTS100%
N/A
ARDX - DRTS
31%
Poorly correlated
+1.91%
HOOK - DRTS
24%
Poorly correlated
N/A
SAGE - DRTS
24%
Poorly correlated
+1.32%
COGT - DRTS
24%
Poorly correlated
+2.29%
XOMA - DRTS
24%
Poorly correlated
+3.26%
More

XOMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, XOMA has been loosely correlated with SYRE. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if XOMA jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XOMA
1D Price
Change %
XOMA100%
+3.26%
SYRE - XOMA
39%
Loosely correlated
+1.68%
SPRY - XOMA
39%
Loosely correlated
-1.37%
GBIO - XOMA
38%
Loosely correlated
+1.51%
BDTX - XOMA
37%
Loosely correlated
-0.77%
YMAB - XOMA
37%
Loosely correlated
+0.94%
More